Advertisement

Topics

Barrier Therapeutics Company Profile

11:54 EDT 23rd September 2018 | BioPortfolio

BARRIER THERAPEUTICS is a pharmaceutical company focused on the discovery, development and commercialization of pharmaceutical products in the field of dermatology. Our goal is to develop a portfolio of innovative products that address major medical needs in the treatment of dermatological diseases and disorders. Our product pipeline includes marketed products and as well as product candidates in various stages of clinical development.

Location

600 College Road East, Suite 3200
Princeton
08540-6697
United States of America

Contact

Phone: (609) 945-1200
Fax: (609) 945-1212


News Articles [902 Associated News Articles listed on BioPortfolio]

Rapid diagnostic coupled with local therapy developed for brain tumours

In the race to deliver therapeutics to treat brain cancer and prevent recurrence, the blood-brain barrier represents a tremendous hurdle. But brain surgery offers a way to circumvent the blood-brain b...

Issues with treating brain cancers through the blood-brain barrier

Dr Phoenix talks to ecancer at the Cancer Research UK Brain Tumour Conference 2018 in London about the blood-brain barrier and the challenges faced when treating brain tumours. He goes on to discuss ...

The xB3 platform efficiently delivers antibodies across the BBB at therapeutic doses

(SAGE) Bioasis Technologies Inc, a biopharmaceutical company developing its xB3 TM proprietary platform technology for the delivery of therapeutics across the blood-brain barrier (BBB) and the treatme...

Implications of the Intestinal Barrier in MS

What role might intestinal barrier function play in neuroinflammation and MS pathophysiology? This paper explores the relationship between MS disease-modifying therapies and gut dysbiosis. Brain

Fiber strengthens intestinal barrier and counteracts gastrointestinal problems

Similar to patients with Crohn's disease, elderly people with stomach problems have a intestinal barrier that is not functioning optimally.

Global Warming Is Transforming the Great Barrier Reef

A new study published online Apr. 18 in Nature shows that corals on the northern Great Barrier Reef experienced a catastrophic die-off following the extended marine heatwave of 2016

Ultrasound Jiggles Open Brain Barrier, A Step To Better Care

ArticleThe so-called blood-brain barrier prevents germs and other damaging substances from leaching in through the bloodstream—but it can block drugs for Alzheimer's, brain tumors, and other neurolo...

This Spanish Biotech’s Drugs Can Cross the Blood-Brain Barrier

Today, we’re in Barcelona visiting iProteos, a biotech that is developing drugs that can cross the blood-brain barrier to treat a range of neurological disorders and schizophrenia. Mission: iProteos...

PubMed Articles [969 Associated PubMed Articles listed on BioPortfolio]

Angubindin-1 opens the blood-brain barrier in vivo for delivery of antisense oligonucleotide to the central nervous system.

Within the field of RNA therapeutics, antisense oligonucleotide-based therapeutics are a potentially powerful means of treating intractable diseases. However, if these therapeutics are used for the tr...

Impact of transporters and enzymes from blood-cerebrospinal fluid barrier and brain parenchyma on CNS drug uptake.

In parallel with the blood-brain barrier (BBB), transporters and enzymes on the blood-cerebrospinal fluid barrier (BCSFB) serve as the first barrier for drug brain uptake. In addition, their expressio...

The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics.

Biological barriers are essential for the maintenance of homeostasis in health and disease. Breakdown of the intestinal barrier is an essential aspect of the pathophysiology of gastrointestinal inflam...

In Situ-Based Gels for Nose to Brain Delivery for the Treatment of Neurological Diseases.

In situ-based gel drug delivery systems that can bypass the blood-brain barrier, deliver the therapeutics to the desired site, reduce peripheral toxicity and control drug release kinetics have been de...

Insulin transport across the blood-brain barrier can occur independent of the insulin receptor.

Insulin enters the brain from the blood via a saturable transport system. It is unclear how insulin is transported across the blood-brain barrier (BBB). Using two models of the signalling-related insu...

Clinical Trials [570 Associated Clinical Trials listed on BioPortfolio]

Effect of Intraorifice Barrier on Healing of Apical Periodontitis

Based on various in-vitro studies intraorifice barrier has been suggested as an effective mean to provide seal against coronal microleakage. This study intends to clinically investigate ef...

DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery

To evaluate the safety and effectiveness of DuraGen Plus® Adhesion Barrier Matrix as an adhesion barrier in spinal surgery to reduce the extent of peridural fibrosis formation and radicul...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

VANOS Cream and Skin Barrier Function

The purpose of this study is to determine the effect of short-term therapy using "VANOS Cream," a super-potent topical steroid cream on skin barrier function in patients with atopic dermat...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Companies [1331 Associated Companies listed on BioPortfolio]

Barrier Therapeutics

BARRIER THERAPEUTICS is a pharmaceutical company focused on the discovery, development and commercialization of pharmaceutical products in the field of dermatology. Our goal is to develop a portfolio ...

Travecta Therapeutics

Travecta Therapeutics is an emerging biotech company developing a platform that leverages our proprietary knowledge of the MFSD2a transport for the targeted delivery of the...

Barrier Advisors Inc.

A nationally recognized financial and operational advisory firm with offices in Dallas, Texas and Stamford, Conn., Barrier Advisors provides special situations investment banking,...

Stiefel Laboratories, Inc., Barrier Therapeutics, Inc., Bengal Acquisition Inc., Mellon Investor Services LLC

Barrier Animal Healthcare

For far too long the control of Ragwort has been haphazard, unreliable and costly, that is until now. Barrier H is an innovation in Ragwort control, destroying this deadly weed in record time, right t...

More Information about "Barrier Therapeutics" on BioPortfolio

We have published hundreds of Barrier Therapeutics news stories on BioPortfolio along with dozens of Barrier Therapeutics Clinical Trials and PubMed Articles about Barrier Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Barrier Therapeutics Companies in our database. You can also find out about relevant Barrier Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record